Literature DB >> 8393785

Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells.

H J Delecluse1, S Schüller, W Hammerschmidt.   

Abstract

Marek's disease virus (MDV), a lymphotropic herpesvirus, induces T-cell lymphomas in chicken, its natural host. The lymphoma cells are latently infected with MDV but the viral contribution to the transformed phenotype is not understood. To investigate the virus-cell interaction, we focused on the status of MDV in the transformed cells. By the use of highly sensitive fluorescent in situ hybridization with metaphase chromosomes, we found (i) MDV DNA to be randomly integrated at multiple sites in the chromosomes of primary lymphoma cells from chicken tissues; (ii) extrachromosomal, circular MDV genomes were absent and linear virion DNA was usually not detectable in the latently infected lymphoma cells; (iii) the pattern of integration sites revealed the clonal origin of the tumour cells; which (iv) was retained in in vitro established cell lines derived from primary lymphomas; (v) activation of the lytic phase of MDV's life cycle occurred in vitro suggesting that MDV can escape from its integrated status by an unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393785      PMCID: PMC413595          DOI: 10.1002/j.1460-2075.1993.tb05997.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  Persisting oncogenic herpesvirus induced by the tumour promotor TPA.

Authors:  H zur Hausen; F J O'Neill; U K Freese; E Hecker
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

3.  Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells.

Authors:  H Zur Hausen; H Schulte-Holthausen
Journal:  Nature       Date:  1970-07-18       Impact factor: 49.962

4.  Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines.

Authors:  B W Calnek; W R Shek; K A Schat
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

5.  Evidence for integrated EBV genomes in Raji cellular DNA.

Authors:  M Anvret; A Karlsson; G Bjursell
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

6.  Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells.

Authors:  C Kaschka-Dierich; L Falk; G Bjursell; A Adams; T Lindahl
Journal:  Int J Cancer       Date:  1977-08-15       Impact factor: 7.396

7.  Induction of Marek's disease virus antigens by IdUrd in a chicken lymphoblastoid cell line.

Authors:  K Dunn; K Nazerian
Journal:  J Gen Virol       Date:  1977-03       Impact factor: 3.891

8.  In vitro infection of lymphocytes with Marek's disease virus.

Authors:  B W Calnek; K A Schat; W R Shek; C L Chen
Journal:  J Natl Cancer Inst       Date:  1982-09       Impact factor: 13.506

9.  Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells.

Authors:  W R Shek; B W Calnek; K A Schat; C H Chen
Journal:  J Natl Cancer Inst       Date:  1983-03       Impact factor: 13.506

10.  Detection of HSV-1 genome in central nervous system of latently infected mice.

Authors:  D L Rock; N W Fraser
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

View more
  34 in total

1.  The Epstein-Barr virus BMRF1 gene is essential for lytic virus replication.

Authors:  Bernhard Neuhierl; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Authors:  M S Parcells; R L Dienglewicz; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

3.  Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome.

Authors:  Clinton R Paden; J Craig Forrest; Nathaniel J Moorman; Samuel H Speck
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

4.  The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro.

Authors:  Jesse H Arbuckle; Maria M Medveczky; Janos Luka; Stephen H Hadley; Andrea Luegmayr; Dharam Ablashi; Troy C Lund; Jakub Tolar; Kenny De Meirleir; Jose G Montoya; Anthony L Komaroff; Peter F Ambros; Peter G Medveczky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

5.  Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.

Authors:  Markus Altmann; Dagmar Pich; Romana Ruiss; Jindong Wang; Bill Sugden; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

6.  Immortalization of human primary B lymphocytes in vitro with DNA.

Authors:  B Kempkes; D Pich; R Zeidler; W Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

7.  Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.

Authors:  E Le Rouzic; P Thoraval; M Afanassieff; Y Cherel; G Dambrine; B Perbal
Journal:  Mol Pathol       Date:  2002-08

8.  Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.

Authors:  Stephen J Spatz; Cary A Rue
Journal:  Virus Genes       Date:  2008-03-20       Impact factor: 2.332

9.  Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.

Authors:  Shane C Burgess; T Fred Davison
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold.

Authors:  Sibille Humme; Gilbert Reisbach; Regina Feederle; Henri-Jacques Delecluse; Kristine Bousset; Wolfgang Hammerschmidt; Aloys Schepers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.